150 related articles for article (PubMed ID: 15811864)
41. Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit.
Leesar MA
Catheter Cardiovasc Interv; 2008 Oct; 72(4):498-9. PubMed ID: 18819148
[No Abstract] [Full Text] [Related]
42. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
[TBL] [Abstract][Full Text] [Related]
43. Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial.
Favarato ME; Hueb W; Boden WE; Lopes N; Nogueira CR; Takiuti M; Góis AF; Borges JC; Favarato D; Aldrighi JM; Oliveira SA; Ramires JA
Int J Cardiol; 2007 Apr; 116(3):364-70. PubMed ID: 16876891
[TBL] [Abstract][Full Text] [Related]
44. "Bolus-only" glycoprotein IIb/IIIa inhibitor use for elective percutaneous coronary intervention: maybe less is more?
Fischell TA
Am Heart J; 2006 Nov; 152(5):812-4. PubMed ID: 17070138
[No Abstract] [Full Text] [Related]
45. Surgery or percutaneous coronary intervention for three-vessel and left main coronary artery disease: a critical appraisal of the literature.
Alison P; Sidebotham D
N Z Med J; 2007 Jun; 120(1255):U2557. PubMed ID: 17546105
[No Abstract] [Full Text] [Related]
46. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
Hlatky MA; Melsop KA; Boothroyd DB;
Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
[TBL] [Abstract][Full Text] [Related]
47. CABG or PCI: which is better? Bypass or angioplasty with stent? For multivessel disease, some say surgery is the superior treatment.
Health News; 2006 May; 12(5):8-10. PubMed ID: 16685751
[No Abstract] [Full Text] [Related]
48. Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS)--study design.
Svilaas T; van der Horst IC; Zijlstra F
Am Heart J; 2006 Mar; 151(3):597.e1-597.e7. PubMed ID: 16504620
[TBL] [Abstract][Full Text] [Related]
49. [Stenting or coronary artery bypass surgery for triple vessel disease?].
Sleilaty G; Achouh P; Fabiani JN
Ann Cardiol Angeiol (Paris); 2009 Apr; 58(2):104-12. PubMed ID: 18930176
[TBL] [Abstract][Full Text] [Related]
50. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
Mahaffey KW; Roe MT; Kilaru R; French JK; Alexander JH; Berdan LG; Van De Werf F; Simoons ML; Weaver WD; White HD; Lincoff AM; Kleiman NS; Topol EJ; Harrington RA
Am J Cardiol; 2005 Jun; 95(12):1404-8. PubMed ID: 15950560
[TBL] [Abstract][Full Text] [Related]
51. Percutaneous coronary intervention: recommendations for good practice and training.
Dawkins KD; Gershlick T; de Belder M; Chauhan A; Venn G; Schofield P; Smith D; Watkins J; Gray HH;
Heart; 2005 Dec; 91 Suppl 6(Suppl 6):vi1-27. PubMed ID: 16365340
[TBL] [Abstract][Full Text] [Related]
52. Left main coronary artery disease: is CABG still the gold standard?
Ng MK; Yeung AC
Rev Cardiovasc Med; 2005; 6(4):187-93. PubMed ID: 16379014
[TBL] [Abstract][Full Text] [Related]
53. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
Martinez-Ojeda J; Martinez-Toro J
Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
[TBL] [Abstract][Full Text] [Related]
54. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
55. Current drug-eluting stents in complex patients and lesions.
Elezi S; Dibra A; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
[TBL] [Abstract][Full Text] [Related]
56. Platelet activation and progression to complications.
Kereiakes DJ; Michelson AD
Rev Cardiovasc Med; 2006; 7(2):75-81. PubMed ID: 16915126
[TBL] [Abstract][Full Text] [Related]
57. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.
Ong AT; Serruys PW; Mohr FW; Morice MC; Kappetein AP; Holmes DR; Mack MJ; van den Brand M; Morel MA; van Es GA; Kleijne J; Koglin J; Russell ME
Am Heart J; 2006 Jun; 151(6):1194-204. PubMed ID: 16781219
[TBL] [Abstract][Full Text] [Related]
58. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
Kimura T; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Abe M; Toma M; Tamura T; Haruna Y; Imai Y; Teramukai S; Fukushima M; Kita T
Circulation; 2008 Sep; 118(14 Suppl):S199-209. PubMed ID: 18824755
[TBL] [Abstract][Full Text] [Related]
59. Impatient for outpatient?
Brinker JA
Catheter Cardiovasc Interv; 2002 May; 56(1):14-5. PubMed ID: 11979525
[No Abstract] [Full Text] [Related]
60. Large cardiac registries: the path to higher quality and lower cost in our healthcare system.
Ryan TJ
Circulation; 2010 Jun; 121(24):2612-4. PubMed ID: 20529995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
